Skip to main content

Zadno Reza's Form 4 filing

PROCEPT BioRobotics Corp (PRCT) · filed Mar 7, 2024

Accession no.
0001628280-24-009763
Filed
Mar 7, 2024
Trade date
Mar 6, 2024
Filing delay
1 day
Rule 10b5-1 plan
Not checked

This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $428.4K. It was filed 1 day after the trade.

This filing was later replaced by the amendment 0001628280-24-017006 (Apr 19, 2024). Trade tables on this site use the amended version.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Zadno RezaCIK 0001632326Director, Officer (President, CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 6, 2024Common StockAGrant or awardAcquired+54,933$0.00$0255,889Direct
Mar 6, 2024Common StockSSaleDisposed−9,179$46.67F3−$428,383.93246,710Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 6, 2024Common StockAGrant or awardAcquired+47,849$0.00$047,849Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F3

The price reported in Column 4 is a weighted average price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)